We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£97.00
It has never been this cheap. We have no record of a lower price.
£97 today · cheaper than every other day in the last 3 months
CRC Press Quantitative Drug Safety and Benefit Risk Evaluation
Price data last checked 68 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 23 days · 23 data points (no recent data)
Price data last checked 68 day(s) ago - refreshing...
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 23 days • 1 price levels
Price Analysis
Most common price: £97 (23 days, 100.0%)
Price range: £97 - £97
Price levels: 1 different prices over 23 days
Description
Key Features
Covers quantitative methodologies and processes for safety monitoring and ongoing benefit risk evaluation.
Explores safety monitoring methodologies including both global trends and regional initiatives.
Addresses the industry shift from individual adverse event reports to aggregate analysis for product risk understanding.
Provides a bridge in knowledge between statisticians and safety scientists with a quantitative interest.
Part of the Chapman and Hall/CRC Biostatistics Series for professional medical and healthcare practitioners.
Product Specifications
- Brand
- CRC Press
- Format
- hardcover
- ASIN
- 1138594067
- Domain
- Amazon UK
- Release Date
- 29 December 2021
- Listed Since
- 31 July 2021
Barcode
No barcode data available
Similar Products You Might Like
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)
CRC Press
Pharmacoepidemiology and Pharmacovigilance: Synergistic Tools to Better Investigate Drug Safety
Elsevier
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)
CRC Press
Pharmacovigilance: A Practical Approach
Elsevier
Price unavailable
Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)
CRC Press
Cobert's Manual Of Drug Safety And Pharmacovigilance (Fourth Edition): 4th Edition
World Scientific Publishing Company
Principles and Practice of Pharmacovigilance and Drug Safety
Springer
Pharmacovigilance
Wiley
Price unavailable
Drug Safety: Pharmacovigilance & Pharmacoepidemiology & Database
CREATESPACE
Wiley Stephens' Detection and Evaluation of Adverse Drug Reactions
Wiley
CRC Press Signal Analysis in Pharmacovigilance Book
CRC Press
Elsevier Pharmacovigilance: A Practical Approach 2nd Edition
Elsevier
Improving Drug Safety - Joint Responsibility Healthcare Book
Springer
Mann's Pharmacovigilance
Wiley
Wiley Stephens' Detection of New Adverse Drug Reactions Book
Wiley
Safety Pharmacology in Pharmaceutical Development: Approval and Post Marketing Surveillance, Second Edition
CRC Press
Statistics in Drug Research: Methodologies and Recent Developments
CRC Press
CRC Press Statistics in Drug Research - Biostatistics Book
CRC Press
Specification of Drug Substances and Products: Development and Validation of Analytical Methods
Elsevier
Pharmacovigilance in the European Union: Practical Implementation across Member States
Springer
Post-Authorization Safety Studies of Medicinal Products: The PASS Book
Elsevier
Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing (Chapman & Hall/CRC Biostatistics Series)
CRC Press
Databases for Pharmacoepidemiological Research (Springer Series on Epidemiology and Public Health)
Springer
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
CRC Press